In a more recent study, 262 patients with symptomatic stricturing CD who were receiving their first anti-TNF therapy (infliximab or adalimumab) and had no prior history of biological, endoscopic, or surgical therapy were included [224]. The gene discussed is TNF; the disease is Cowden disease.